MAIA
MAIA Biotechnology, Inc.
Latest Form 4:Purchase$3KbyGryaznov Sergei (Chief Scientific Officer) · filed Jun 2, 2026
MAIA Biotechnology, Inc. (MAIA) has 7 SEC Form 4 filings (8 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jun 2, 2026.
The most active filer is Director Smith Stan with 3 filings. Insiders have net bought $434K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Vlad Vitoc
- Employees:13
- HQ:Chicago, IL, US
- IPO:2022-07-28
Insider Buying
$434K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$85.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Gryaznov SergeiFirst filing | Chief Scientific Officer | Purchase | 2,000 | $3K | Jun 2 | SEC ↗ |
Vitoc VladFirst filing | Chief Executive Officer | Purchase | 72,700 | $101K | Jun 2 | SEC ↗ |
Smith StanFirst in 5 months | Director | Purchase | 75,000 | $100K | Jun 2 | SEC ↗ |
| Director | Purchase | 2,700 | $10K | Jan 12 | SEC ↗ | |
CHAOUKI STEVEN MFirst filing | Director | Purchase | 40,849 | $50K | Dec 23 | SEC ↗ |
Louie Ngar YeeFirst filing | Director | Purchase | 81,699 | $100K | Dec 23 | SEC ↗ |
Smith StanFirst filing | Director | Purchase | 57,189 | $70K | Dec 23 | SEC ↗ |
Related companies
MAIA Biotechnology, Inc. is in the Healthcare sector.